JPH07227289A - Microorganism metabolite and antitumor agent comprising the same as active ingredient - Google Patents

Microorganism metabolite and antitumor agent comprising the same as active ingredient

Info

Publication number
JPH07227289A
JPH07227289A JP6039144A JP3914494A JPH07227289A JP H07227289 A JPH07227289 A JP H07227289A JP 6039144 A JP6039144 A JP 6039144A JP 3914494 A JP3914494 A JP 3914494A JP H07227289 A JPH07227289 A JP H07227289A
Authority
JP
Japan
Prior art keywords
medium
culture
metabolite
microorganism
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6039144A
Other languages
Japanese (ja)
Inventor
Tokiyuki Hiramitsu
時幸 平光
Chiaki Yasuhara
千晶 安原
Katsunori Suzuki
功徳 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Mektron KK
Original Assignee
Nippon Mektron KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Mektron KK filed Critical Nippon Mektron KK
Priority to JP6039144A priority Critical patent/JPH07227289A/en
Publication of JPH07227289A publication Critical patent/JPH07227289A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a hydrophobic substance having antitumor activity, as a metabolite of a microorganism of Cordyceps ophioglossoides. CONSTITUTION:Cordyceps ophioglossoides (IFO8, 992) is used and its culture medium is extracted with an organic solvent to give a metabolite of a microorganism as a hydrophobic substance. The substance completely suppresses proliferation of mouse tumor cell YAC-1 in concentration of about 0.1-0.0125mug/ml and is recognized to have antitumor action.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、微生物代謝産物および
それを有効成分とする抗腫瘍剤に関する。更に詳しく
は、微生物コージセプス オフィオグロソィデスを培養
して得られる微生物代謝産物およびそれを有効成分とす
る抗腫瘍剤に関する。
TECHNICAL FIELD The present invention relates to a microbial metabolite and an antitumor agent containing the same as an active ingredient. More specifically, it relates to a microbial metabolite obtained by culturing a microorganism Koji Ceps ophiogrosides and an antitumor agent containing the same.

【0002】[0002]

【従来の技術】コージセプス属の微生物には、真核細胞
に寄生する多くのキノコ類が含まれ、その代謝産物中に
は真核細胞の増殖を抑制する物質が含まれるものと期待
され、多くの研究がなされているが、その多くは免疫活
性機能を有する多糖類に関するものである。
2. Description of the Related Art Microorganisms of the genus Cordyceps contain many mushrooms that parasitize eukaryotic cells, and their metabolites are expected to contain substances that suppress the growth of eukaryotic cells. However, most of them are related to polysaccharides having an immunoreactive function.

【0003】細胞毒性作用を有する化合物としては、コ
ージセプス ミリタリスの培養液中から見出されたコー
ジセピンおよびコージセプス オフィオグロソィデスの
培養液中から見出されたガラクトサミノグリカンが知ら
れているにすぎないが(J.Chem.Soc.1951年第2299
頁、EP 067 000、Chem.Pharm. Bull. 第36巻第4505
頁,1988年)、これらの化合物はいずれも親水性物質で
あって、in vitro での細胞毒性は強いとはいえず、現
在迄のところ強い細胞毒性を有する疎水性物質は見出さ
れていない。
As the compounds having a cytotoxic effect, cordycepin found in the culture medium of Kojicep militaryalis and galactosaminoglycan found in the culture medium of Kojicep Ophioglossoides are only known. No, but (J. Chem. Soc. 1951 No. 2299
Page, EP 067 000, Chem. Pharm. Bull. Volume 36 Volume 4505
(Page, 1988), all of these compounds are hydrophilic substances, and it cannot be said that they have strong in vitro cytotoxicity. So far, no hydrophobic substance having strong cytotoxicity has been found. .

【0004】[0004]

【発明が解決しようとする課題】本発明の目的は、コー
ジセプス オフィオグロソィデスの微生物代謝産物であ
って、抗腫瘍活性を有する疎水性物質を提供することに
ある。
DISCLOSURE OF THE INVENTION An object of the present invention is to provide a hydrophobic substance which is a microbial metabolite of Cordyceps ophiogrosoides and has antitumor activity.

【0005】[0005]

【課題を解決するための手段】かかる本発明の目的は、
微生物コージセプス オフィオグロソィデス(IFO 8992)
の培養培地を有機溶媒で抽出して得られる抽出物よりな
る微生物代謝産物によって達成される。
The object of the present invention is as follows.
Microbial Koji Seps Ophioglossoides (IFO 8992)
It is achieved by a microbial metabolite consisting of an extract obtained by extracting the culture medium of 1. with an organic solvent.

【0006】微生物コージセプス オフィオグロソィデ
ス(Cordyceps ophioglossoides)は、古来より重要な漢
方薬として用いられている冬虫夏草(コージセプス シネ
ンシス)と同属に属し、日本ではハナヤスリタケと呼ば
れ、ツチダンゴ類に寄生するキノコの一種である。本発
明においては、それの培養培地を有機溶媒で抽出して得
られる抽出物が微生物代謝産物として取得される。
[0006] The microorganism Koji Ceps ophioglossoides belongs to the same genus as Cordyceps sinensis, which has been used as an herbal medicine that has been important since ancient times. It is a kind. In the present invention, an extract obtained by extracting the culture medium with an organic solvent is obtained as a microbial metabolite.

【0007】コージセプス オフィオグロソィデスの培
養は、通常の真菌培養法によって行われる。即ち、静置
培養法または振とう培養法が用いられ、培地としてはこ
の菌株が利用し得る栄養源を含有するものであれば、合
成培地、半合成培地、天然培地のいずれをも用いること
ができる。
Codyceptus ophiogrosides is cultivated by a usual fungal culture method. That is, a static culture method or a shaking culture method is used, and as the medium, any of synthetic medium, semi-synthetic medium and natural medium may be used as long as it contains a nutrient source that can be utilized by this strain. it can.

【0008】培地中には、例えば炭素源としてぶとう
糖、麦芽糖、しょ糖、デキストリン、グリセリン、でん
粉、じゃがいも煎汁、おがくず、コーンミル等が、窒素
源として麦芽エキス、大豆粉、コーン・スチーブ・リカ
ー、綿実粉、肉エキス、酵母エキス、ペプトン、じゃが
いも煎汁、カゼイン加水分解物、乾燥酵母、米ぬか、ア
ミノ酸類、アンモニウム塩、硝酸塩等が、また必要に応
じて無機塩としてナトリウム、カリウム、マグネシウ
ム、カルシウム、亜鉛、鉄等の硫酸塩、硝酸塩、炭酸
塩、リン酸塩、塩化物等がそれぞれ含有され、培地が固
体培地として用いられる場合には、更にゲル化剤として
寒天、ゼラチン、シリカゲル、ゲランガム等が含有され
る。
In the medium, for example, dextrose, maltose, sucrose, dextrin, glycerin, starch, potato decoction, sawdust, corn mill, etc. as carbon sources, malt extract, soybean powder, corn steve liquor as nitrogen sources. , Cottonseed flour, meat extract, yeast extract, peptone, potato decoction, casein hydrolyzate, dry yeast, rice bran, amino acids, ammonium salts, nitrates, etc., and if necessary, inorganic salts such as sodium, potassium and magnesium. , Calcium, zinc, iron and other sulfates, nitrates, carbonates, phosphates, chlorides and the like, respectively, when the medium is used as a solid medium, further agar, gelatin, silica gel, as a gelling agent, Gellan gum and the like are contained.

【0009】培養は、好気的条件下で行うのが一般的に
有利であり、培養温度としては約20〜30℃、pHは約5〜8
の範囲がそれぞれ好ましく、また培養時間は培地の組
成、培養温度などにより変動するが、一般には1週間か
ら1ヶ月程度であり、この間に抗腫瘍物質が培地中に生
成蓄積される。
It is generally advantageous to carry out the culture under aerobic conditions. The culture temperature is about 20 to 30 ° C. and the pH is about 5 to 8.
The respective ranges are preferable, and the culture time varies depending on the composition of the medium, the culture temperature, etc., but is generally about 1 week to 1 month, during which the antitumor substance is produced and accumulated in the medium.

【0010】培地中に生成蓄積された抗腫瘍物質の培地
からの採取は、微生物の培養培地より疎水性成分を分離
する通常の手段を、適宜選択し組み合わせることによっ
て行われ、その概略を示すと次の如くである。
The antitumor substance produced and accumulated in the medium is collected from the medium by appropriately selecting and combining ordinary means for separating the hydrophobic component from the culture medium of the microorganism. It is as follows.

【0011】即ち、液体培地から抗腫瘍物質を分離する
場合には、培養後の培地から菌糸体を除去後、酢酸エチ
ルで抽出する。抽出液を濃縮乾固すればその残渣として
抗腫瘍作用を有する代謝産物が得られる。固体培地から
抗腫瘍物質を分離する場合には、固体培地を粉砕した
後、抗腫瘍物質を溶解せしめる有機溶媒、例えばメタノ
ール、n-ブタノール等のアルコール中にけん濁し、室温
条件下または加熱条件下に抽出し、抽出液から固形物を
除去した後、60℃以下の温度で減圧濃縮乾固し、残渣か
ら水溶性部分を除去すれば抗腫瘍作用を有する疎水性の
代謝産物が得られる。
That is, when the antitumor substance is separated from the liquid medium, the mycelium is removed from the medium after culturing and then extracted with ethyl acetate. When the extract is concentrated to dryness, a metabolite having an antitumor effect is obtained as the residue. In the case of separating the antitumor substance from the solid medium, after crushing the solid medium, the solid medium is suspended in an organic solvent capable of dissolving the antitumor substance, for example, alcohol such as methanol or n-butanol, and at room temperature or under heating conditions. After removing the solid matter from the extract, the mixture is concentrated to dryness under reduced pressure at a temperature of 60 ° C or lower, and the water-soluble portion is removed from the residue to obtain a hydrophobic metabolite having an antitumor effect.

【0012】[0012]

【発明の効果】コージセプス オフィオグロソィデス(IF
O 8992)を用い、この培養培地を有機溶媒で抽出するこ
とにより、疎水性物質としての微生物代謝産物が得られ
る。この物質は、約0.1〜0.0125μg/mlの濃度でマウス
腫瘍細胞YAC-1の増殖を完全に抑制し、抗腫瘍作用
のあることが認められた。
[Advantages of the Invention] Koji Cepth Ophioglossoids (IF
O 8992) is used to extract this culture medium with an organic solvent to obtain a microbial metabolite as a hydrophobic substance. This substance completely suppressed the growth of mouse tumor cells YAC-1 at a concentration of about 0.1 to 0.0125 μg / ml, and was found to have an antitumor effect.

【0013】[0013]

【実施例】次に、実施例について本発明を説明する。EXAMPLES The present invention will now be described with reference to examples.

【0014】実施例1 コージセプス オフィオグロソィデス(IFO 8992)の傾斜
培養物の一白金耳を、容量200mlのエルレンマイヤーフ
ラスコ内の種培養用培地(栄研化学製品ポテトデキスト
ロース寒天培地39gを蒸留水1Lにけん濁し、不溶寒天
部分をロ別した後、オートクレーブ中で120℃、15分間
の滅菌処理をしたもの)20mlに接種し、25℃で20日間静
置培養した。この培養液20mlを、本培養用培地(栄研化
学製品ポテトデキストロース寒天培地39gを蒸留水1L
にけん濁し、オートクレーブ中で120℃、15分間の滅菌
処理をした後、長さ30cm、幅22cm、深さ6cmのステンレ
ス鋼製ふた付きバットに注入して調製したもの)の表面
に均一に接種した後、滅菌したナイフで約2cm角のサイ
コロ状に切断した。それぞれのサイコロ状培地は、空気
との接触をよくするため、相互に密着しないように、バ
ット内に不規則に配置され、25℃で21日間暗所で静置培
養した。
Example 1 One platinum loop of a tilted culture of Koji Ceps ophiogrosides (IFO 8992) was placed in a medium for seed culture in an Erlenmeyer flask with a capacity of 200 ml (39 g of Eiken Chemical's potato dextrose agar medium was distilled). After suspending in 1 L of water and separating the insoluble agar portion by filtration, 20 ml of the product (sterilized at 120 ° C. for 15 minutes) was inoculated in an autoclave and statically cultured at 25 ° C. for 20 days. 20 ml of this culture solution was used as a medium for main culture (Eiken Chemical Co., Ltd., potato dextrose agar medium 39 g, distilled water 1 L).
Suspended in water, sterilized in an autoclave at 120 ° C for 15 minutes, and then injected into a stainless steel lid vat with a length of 30 cm, a width of 22 cm, and a depth of 6 cm) to uniformly inoculate the surface. After that, it was cut into about 2 cm square dice with a sterilized knife. In order to improve the contact with air, each dice-shaped medium was randomly placed in a vat so as not to adhere to each other, and statically cultured at 25 ° C. for 21 days in the dark.

【0015】培養後の培地を、加熱して溶融させた後、
500mlのn-ブタノールを加え、100℃で3時間撹拌した。
室温に冷却した後、固化した寒天培地から分離したn-ブ
タノール層を濃縮乾固した。得られた残渣に、水100ml
および酢酸エチル200mlを加えて分液した後、酢酸エチ
ル層を50℃以下の温度で濃縮乾固し、微生物代謝産物13
7mgを褐色のアメ状物質として得た。
After the culture medium is heated and melted,
500 ml of n-butanol was added, and the mixture was stirred at 100 ° C for 3 hours.
After cooling to room temperature, the n-butanol layer separated from the solidified agar medium was concentrated to dryness. 100 ml of water is added to the obtained residue.
And 200 ml of ethyl acetate were added for liquid separation, and then the ethyl acetate layer was concentrated to dryness at a temperature of 50 ° C or lower to obtain microbial metabolites 13
7 mg was obtained as a brown candy.

【0016】実施例2 実施例1において、本培養用培地として麦芽エキス含有
寒天培地(DIFCO製品麦芽エキス10g、DIFCO製品 BACTO-
ペプトン1g、ブドウ糖40gおよび寒天20gを蒸留水1Lに
けん濁し、オートクレーブ中で120℃、15分間の滅菌処
理をした後、長さ30cm、幅22cm、深さ6cmのステンレス
鋼製ふた付きバットに注入して調製したもの)を用い、
微生物代謝産物115mgを褐色のアメ状物質として得た。
Example 2 In Example 1, malt extract-containing agar medium was used as the main culture medium (malt extract 10 g of DIFCO product, BACTO-product of DIFCO product).
Peptone (1 g), glucose (40 g) and agar (20 g) were suspended in distilled water (1 L), sterilized in an autoclave at 120 ° C for 15 minutes, and then poured into a stainless steel lid vat with a length of 30 cm, a width of 22 cm, and a depth of 6 cm. (Prepared by
115 mg of microbial metabolite was obtained as a brown candy.

【0017】実施例3 コージセプス オフィオグロソィデス(IFO 8992)の傾斜
培養物の一白金耳を、種培養用培地(栄研化学製品ポテ
トデキストロース寒天培地39gを蒸留水1Lにけん濁
し、オートクレーブ中で120℃、15分間の滅菌処理をし
た後、熱時に10mlずつ、径9cm、深さ20mmのシャーレに
分注したもの)の1枚の中心に接種し、25℃で7日間静置
培養した。このようにして得られた円形のコロニーを、
滅菌したメスで約20等分し、その全部を本培養用培地
(実施例1での種培養用培地と同じ組成の培地)1Lを含
む容量5Lのエルレンマイヤーフラスコ中に接種し、25
℃で2週間、暗所で静置培養した。
Example 3 One platinum loop of a tilted culture of Koji Ceps ophiogrosides (IFO 8992) was suspended in a seed culture medium (Eiken Chemical Co., Ltd. potato dextrose agar medium 39 g in distilled water 1 L) in an autoclave. After sterilization at 120 ° C. for 15 minutes, 10 ml of each was inoculated into a center of a petri dish having a diameter of 9 cm and a depth of 20 mm when heated, and the mixture was inoculated at 25 ° C. for 7 days. The circular colonies obtained in this way are
Divide into approximately 20 equal parts with a sterilized scalpel, and all of them are the main culture medium.
(A medium having the same composition as the medium for seed culture in Example 1) Inoculate into a 5 L Erlenmeyer flask containing 1 L, and
The cells were cultivated in the dark at static temperature for 2 weeks.

【0018】培養終了後、菌糸体をロ別し、ロ液を水で
2倍に希釈した後、酢酸エチル1Lで2回抽出した。酢
酸エチル層を水洗した後、50℃以下の温度で濃縮乾固
し、微生物代謝産物95mgを褐色のアメ状物質として得
た。
After completion of the culture, the mycelium was separated by filtration, the filtrate was diluted with water twice, and then extracted twice with 1 L of ethyl acetate. The ethyl acetate layer was washed with water and then concentrated to dryness at a temperature of 50 ° C. or lower to obtain 95 mg of a microbial metabolite as a brown candy-like substance.

【0019】実施例4 実施例3において、本培養用培地(DIFCO製品 麦芽エキ
ス10g、DIFCO製品 BACTO-ペプトン1gおよびブドウ糖40g
を蒸留水1Lに溶解した後、120℃、15分間の滅菌処理
をしたもの)1Lを含む容量5Lのエルレンマイヤーフラ
スコ中に、実施例3の円形のコロニーを約20等分したも
のを種菌として接種し、25℃で21日間振とう培養した。
Example 4 In Example 3, the medium for main culture (DIFCO product malt extract 10 g, DIFCO product BACTO-peptone 1 g and glucose 40 g)
Was dissolved in 1 L of distilled water and then sterilized at 120 ° C. for 15 minutes) In a 5 L Erlenmeyer flask containing 1 L, the round colony of Example 3 was divided into about 20 equal parts Then, the cells were shake-cultured at 25 ° C for 21 days.

【0020】培養終了後、培地にエタノール1Lを加え
て不溶物をロ別し、ロ液を60℃以下の温度で濃縮乾固し
た。残渣に、水200mlを加えた後、酢酸エチル200mlで抽
出した。酢酸エチル層を水洗した後、50℃以下の温度で
濃縮乾固して、微生物代謝産物95mgを褐色のアメ状物質
として得た。
After completion of the culture, 1 L of ethanol was added to the medium to separate insoluble matter by filtration, and the filtrate was concentrated to dryness at a temperature of 60 ° C or lower. After adding 200 ml of water to the residue, the mixture was extracted with 200 ml of ethyl acetate. The ethyl acetate layer was washed with water and then concentrated to dryness at a temperature of 50 ° C. or lower to obtain 95 mg of a microbial metabolite as a brown candy-like substance.

【0021】[腫瘍細胞増殖抑制試験]マウス腫瘍細胞Y
AC-1 106cells/mlを含むRPMI 1640培地(10%のFC
S,100U/mlのペニシリンおよび100μg/mlのストレプト
マイシン添加)100μlを、96穴マイクロプレート各ウェ
ルに分注し、更に各種濃度の前記各実施例で得られた微
生物代謝産物(5%ジメチルスルホキシド溶液を前述のR
PMI 1640培地で希釈し、各所定濃度に調整したもの)
100μlを各ウェルに加え、37℃、5%CO2のインキュベー
タ内で、72時間培養した。培地の色の変化をコントロー
ルと比較して、腫瘍細胞の増殖の有無を判定した結果、
腫瘍細胞の増殖を完全に抑制する濃度として、次のよう
な結果が得られた。微生物代謝産物 濃度(μg/ml) 実施例1 0.1 実施例2 0.05 実施例3 0.025 実施例4 0.0125
[Tumor cell growth inhibition test] Mouse tumor cell Y
RPMI 1640 medium containing AC-1 10 6 cells / ml (10% of the FC
100 μl of S, 100 U / ml penicillin and 100 μg / ml streptomycin was added to each well of a 96-well microplate, and the microbial metabolites (5% dimethylsulfoxide solution) obtained in each of the above Examples at various concentrations To the above R
(Diluted with PMI 1640 medium and adjusted to each prescribed concentration)
100 μl was added to each well and incubated at 37 ° C. in a 5% CO 2 incubator for 72 hours. As a result of determining the presence or absence of proliferation of tumor cells by comparing the change in color of the medium with a control,
The following results were obtained as the concentration at which the growth of tumor cells was completely suppressed. Microbial metabolite concentration (μg / ml) Example 1 0.1 Example 2 0.05 Example 3 0.025 Example 4 0.0125

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 微生物コージセプス オフィオグロソィ
デス(IFO 8992)の培養培地を有機溶媒で抽出して得られ
る抽出物よりなる微生物代謝産物。
1. A microbial metabolite consisting of an extract obtained by extracting a culture medium of microbial cordyceps ophioglosides (IFO 8992) with an organic solvent.
【請求項2】 請求項1記載の微生物代謝産物を有効成
分とする抗腫瘍剤。
2. An antitumor agent comprising the microbial metabolite according to claim 1 as an active ingredient.
JP6039144A 1994-02-14 1994-02-14 Microorganism metabolite and antitumor agent comprising the same as active ingredient Pending JPH07227289A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6039144A JPH07227289A (en) 1994-02-14 1994-02-14 Microorganism metabolite and antitumor agent comprising the same as active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6039144A JPH07227289A (en) 1994-02-14 1994-02-14 Microorganism metabolite and antitumor agent comprising the same as active ingredient

Publications (1)

Publication Number Publication Date
JPH07227289A true JPH07227289A (en) 1995-08-29

Family

ID=12544919

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6039144A Pending JPH07227289A (en) 1994-02-14 1994-02-14 Microorganism metabolite and antitumor agent comprising the same as active ingredient

Country Status (1)

Country Link
JP (1) JPH07227289A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2013035473A1 (en) * 2011-09-07 2015-03-23 国立大学法人信州大学 Method for producing useful metabolites from filamentous fungi

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2013035473A1 (en) * 2011-09-07 2015-03-23 国立大学法人信州大学 Method for producing useful metabolites from filamentous fungi
US9834796B2 (en) 2011-09-07 2017-12-05 Shinshu University Method for producing useful metabolite from filamentous fungus

Similar Documents

Publication Publication Date Title
CA1046439A (en) Physiologically active substances from penicillium citrinum
US4032663A (en) Process for using cell wall-lysing enzymes
KR100199920B1 (en) The method of culturing cordyceps
US3892850A (en) Pimaricin and process of producing same
SE453301B (en) ANTIHYPERCOLESTEROLEMIC MEDICINE, MONACOLINE K, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
JPH01228480A (en) Production of extract of cultured mycelia of edible basidiomycete
US7037711B2 (en) Process for producing a culture of Antrodia camphorata and product obtained thereby
KR101023923B1 (en) Process for producing glutathione
US3969189A (en) Cell wall-lysing complex enzymes and a process for the production thereof
JPH07227289A (en) Microorganism metabolite and antitumor agent comprising the same as active ingredient
JPH04304890A (en) Production of ganoderic acids
KR0177356B1 (en) How to increase the productivity of Monasukus pigment
Vahidi et al. Effects of carbon sources on growth and production of antifungal agents by Gymnopilus spectabilis
JPH07227294A (en) Production of pseurotin a
US20010051195A1 (en) Methods and compositions for increasing fermentation of a microorganism
JPS6153033B2 (en)
US4992570A (en) UCN-1028A and UCN-1028C and process for the production thereof
JPH0710736A (en) Cosmetic
Boeck et al. A32390A, A NEW BIOLOGICALLY ACTIVE METABOLITE I. DISCOVERY AND FERMENTATION STUDIES
JPS633577B2 (en)
JP2578486B2 (en) New substance KS-502
US3485722A (en) Fermentative process for producing ergocryptine
JP4629442B2 (en) Process for producing β-L-homofuconojirimycin by microorganism
FR2598085A1 (en) NOVEL ALDOSE REDUCTASE INHIBITING SUBSTANCE AND PROCESS FOR PREPARING THE SAME
JPS6043387A (en) Antitumor agent and its preparation